revottack
/ Huawe Medicine, Affiliated Hospital of Xuzhou Medical University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 09, 2022
Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: The Affiliated Hospital of Xuzhou Medical University
New P1 trial • Oncolytic virus • Dental Disorders • Gastrointestinal Cancer • Oncology • Solid Tumor • Stomatitis
1 to 1
Of
1
Go to page
1